Observational study on clot-busting drugs beyond the usual window
Part of Brain & nervous system, Heart & circulation clinical trials.
This study looks at patients who received a clot-busting drug (intravenous thrombolysis) for their stroke 4.5 to 24 hours after symptoms started. It aims to see how well this works and what happens to them, using data that has already been collected.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You had an ischemic stroke (a stroke caused by a clot)
- You are 18 years or older
- You received treatment with a clot-busting drug between 4.5 and 24 hours after your stroke began (the time of onset is when you were last seen normal)
- You have records that include your gender, age, and scores that measure your disability (mRS and NIHSS)
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study tracks patients who receive IV thrombolysis (a clot-busting medication injected into the vein) for acute ischemic stroke more than 4.5 hours after their stroke started. Researchers want to learn whether this extended-window treatment can still help patients recover when given outside the typical time window.
This study compares two medications, tenecteplase and alteplase, to see which works better at dissolving blood clots in people having an ischemic stroke. You may join if you can get treatment within 4.5 hours of when your symptoms started.
This trial tests a new approach for treating acute ischemic stroke within 4.5 hours of symptoms starting. It combines a special mobile stroke unit that delivers early brain-protecting medicine with standard clot-busting or clot-removal procedures, to see if this can improve recovery.
This trial tests a single dose of a new clot-dissolving medicine for people who had a stroke 4.5 to 24 hours ago. It may help if you cannot have standard treatments like a clot-removal procedure or other clot-busting drugs.
This study records information from adults with an acute ischemic stroke (a stroke caused by a blocked artery) who receive clot-busting medicine within 4.5 hours. It may help doctors better understand which patients benefit from treatment and how care decisions are made for certain blocked brain arteries.
This trial tests whether a clot-busting medication given through a vein (intravenous thrombolysis) can safely treat acute ischemic stroke within 24 hours in people who have taken a newer oral blood thinner (NOAC) within the last 4 to 48 hours.
Hear when a new Stroke trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.